Literature DB >> 32520019

Toward multifunctional anticancer therapeutics: post-synthetic carbonate functionalisation of asymmetric Au(i) bis-N-heterocyclic carbenes.

Sajal Sen1, Mark W Perrin, Adam C Sedgwick, Evie Y Dunsky, Vincent M Lynch, Xiao-Peng He, Jonathan L Sessler, Jonathan F Arambula.   

Abstract

A post-synthetic strategy is reported that allows for functionalisation of Au(i)-bis NHCs via carbonate formation. The scope of this methodology was explored using both aromatic and aliphatic alcohols. As a demonstration of potential utility, the fluorescent Au(i)-bis NHC conjugate 5 was prepared; it was found to have enhanced stability when formulated with bovine serum albumin, localise within the mitochondria of A549 cells and do so without compromising the high cytotoxicity seen for the parent Au(i)-bis NHC system.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32520019      PMCID: PMC7368814          DOI: 10.1039/d0cc03339a

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  35 in total

1.  Expanding the biological utility of bis-NHC gold(i) complexes through post synthetic carbamate conjugation.

Authors:  Sajal Sen; Yue Li; Vincent Lynch; Kuppuswamy Arumugam; Jonathan L Sessler; Jonathan F Arambula
Journal:  Chem Commun (Camb)       Date:  2019-08-29       Impact factor: 6.222

2.  Fluorescent functionalised naphthalimides and their Au(i)-NHC complexes for potential use in cellular bioimaging.

Authors:  Lara M Groves; Catrin F Williams; Anthony J Hayes; Benjamin D Ward; Marc D Isaacs; Nadine O Symonds; David Lloyd; Peter N Horton; Simon J Coles; Simon J A Pope
Journal:  Dalton Trans       Date:  2018-12-19       Impact factor: 4.390

Review 3.  Understanding and improving platinum anticancer drugs--phenanthriplatin.

Authors:  Timothy C Johnstone; Ga Young Park; Stephen J Lippard
Journal:  Anticancer Res       Date:  2014-01       Impact factor: 2.480

4.  Amino acid-linked platinum(II) analogues have altered specificity for RNA compared to cisplatin.

Authors:  Keshab Rijal; Xun Bao; Christine S Chow
Journal:  Chem Commun (Camb)       Date:  2014-01-13       Impact factor: 6.222

Review 5.  Fluorescent chemosensors: the past, present and future.

Authors:  Di Wu; Adam C Sedgwick; Thorfinnur Gunnlaugsson; Engin U Akkaya; Juyoung Yoon; Tony D James
Journal:  Chem Soc Rev       Date:  2017-10-11       Impact factor: 54.564

6.  Oxaliplatin Pt(IV) prodrugs conjugated to gadolinium-texaphyrin as potential antitumor agents.

Authors:  Grégory Thiabaud; Guangan He; Sajal Sen; Kathryn A Shelton; Wallace B Baze; Luke Segura; Julie Alaniz; Ruben Munoz Macias; Greg Lyness; Alan B Watts; Hyun Min Kim; Hyunseung Lee; Mi Young Cho; Kwan Soo Hong; Rick Finch; Zahid H Siddik; Jonathan F Arambula; Jonathan L Sessler
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-16       Impact factor: 11.205

Review 7.  Seek & Destroy, use of targeting peptides for cancer detection and drug delivery.

Authors:  Vadim Le Joncour; Pirjo Laakkonen
Journal:  Bioorg Med Chem       Date:  2017-09-01       Impact factor: 3.641

8.  A texaphyrin-oxaliplatin conjugate that overcomes both pharmacologic and molecular mechanisms of cisplatin resistance in cancer cells.

Authors:  Jonathan F Arambula; Jonathan L Sessler; Zahid H Siddik
Journal:  Medchemcomm       Date:  2012       Impact factor: 3.597

9.  Gemcitabine-coumarin-biotin conjugates: a target specific theranostic anticancer prodrug.

Authors:  Sukhendu Maiti; Nayoung Park; Ji Hye Han; Hyun Mi Jeon; Jae Hong Lee; Sankarprasad Bhuniya; Chulhun Kang; Jong Seung Kim
Journal:  J Am Chem Soc       Date:  2013-03-12       Impact factor: 15.419

10.  Biscarbene gold(i) complexes: structure-activity-relationships regarding antibacterial effects, cytotoxicity, TrxR inhibition and cellular bioavailability.

Authors:  Claudia Schmidt; Bianka Karge; Rainer Misgeld; Aram Prokop; Mark Brönstrup; Ingo Ott
Journal:  Medchemcomm       Date:  2017-06-27       Impact factor: 3.597

View more
  1 in total

1.  Rationally Designed Redox-Active Au(I) N-Heterocyclic Carbene: An Immunogenic Cell Death Inducer.

Authors:  Sajal Sen; Stephanie Hufnagel; Esther Y Maier; Isaiah Aguilar; Jayaraman Selvakumar; Jennie E DeVore; Vincent M Lynch; Kuppuswamy Arumugam; Zhengrong Cui; Jonathan L Sessler; Jonathan F Arambula
Journal:  J Am Chem Soc       Date:  2020-11-25       Impact factor: 16.383

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.